Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
about
Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies.Headache induced by serotonergic agonists--a key to the interpretation of migraine pathogenesis?Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans.Pituitary-adrenal responses to combined oral D-fenfluramine and intravenous naloxone in humans.Comparison of buspirone with diazepam and fluvoxamine on aversive classical conditioning in humans.The effects of D-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function.
P2860
Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
@en
Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
@nl
type
label
Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
@en
Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
@nl
prefLabel
Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
@en
Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
@nl
P2093
P1476
Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
@en
P2093
P304
P356
10.1016/0165-0327(94)90039-6
P577
1994-02-01T00:00:00Z